Management of locally recurrent breast cancer

Cancer

Volumn 71, Issue 7, 1993, Pages 2395-2409

  Kennedy, M John ^a   Abeloff, Martin D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

breast cancer; locoregional relapse; radiation therapy; systemic therapy

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONSERVATIVE TREATMENT; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE RISK; REVIEW; TUMOR LOCALIZATION;

BREAST NEOPLASMS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; EVALUATION STUDIES; FEMALE; HUMAN; NEOPLASM RECURRENCE, LOCAL;

EID: 0027534960     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930401)71:7<2395::AID-CNCR2820710735>3.0.CO;2-C     Document Type: Review

References (125)

1. The results of operations for the cure of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894
2. An improved method of the radical operation for carcinoma of the breast
3. A study of the results of operations for the cure of cancer of the breast
4. Skin removal in radical breast amputation
5. Evaluation of skin grafting in technique of radical mastectomy in relation of local recurrence of carcinoma
6. The problem of local recurrence after radical mastectomy for carcinoma: skin removal in radical mastectomy
7. The clinical significance of skin recurrence after radical mastectomy in women with cancer of the breast
8. Late local recurrent carcinoma of the breast
9. A biostatistical study of locally recurrent breast carcinoma
10. Local recurrence of breast cancer
11. The implications of local recurrence of breast cancer as the first site of therapeutic failure
12. Carcinoma of the breast: II. Criteria of operability
13. Cancer of the breast, 1661 patients: I. Considerations in future therapy
14. Frequency, anatomical distribution and management of local recurrences after definitive therapy for breast cancer
15. The nature of local recurrence following radical mastectomy
16. Significance of the extent of axillary metastases in carcinoma of the female breast
17. Local recurrence following mastectomy
18. Patterns of flap recurrence following mastectomy
19. Tumor hormone receptor status and recurrences in premenopausal node negative breast carcinoma
20. Local recurrences in patients with breast cancer at the North Carolina Memorial Hospital (1970–1982)
21. Low incidence of local recurrence after conservative operations for cancer of the breast
22. Survival following local skin recurrence after mastectomy
23. Natural history and prognosis of recurrent breast cancer
24. Prognostic analysis of recurrent breast cancer
25. Conservative radical mastectomy
26. The significance of recurrence in breast cancer
27. Relapse pattern and follow‐up of breast cancer
28. The role of residual tumor in the chest wall in the late dissemination of mammary cancer
29. The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy
30. Prognostic indicators in patients with isolated local‐regional recurrence of breast cancer
31. The results of radiation therapy for isolated local regional recurrence after mastectomy
32. Locally recurrent carcinoma of the breast: results of radiation therapy
33. Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients
34. Radiation therapy for localregional recurrent breast cancer
35. Isolated local‐regional recurrence of breast cancer following mastectomy: radiotherapeutic management
36. The significance of local‐recurrence in carcinoma of the breast
37. Local control and outcome of patients irradiated for isolated chest wall recurrences of breast cancer
38. Survival after first recurrence in breast cancer
39. The role of radiotherapy following total mastectomy for patients with early breast cancer
40. Prognosis and treatment of locoregional breast cancer recurrences: critical considerations on 120 cases
41. Results of irradiation in the treatment of locoregional breast cancer recurrence
42. An evaluation of postoperative prophylactic radiation therapy in breast cancer
43. Postoperative radiotherapy in breast cancer
44. Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial
45. The effect of postoperative radiotherapy in breast cancer
46. Adjuvant radiotherapy in operable breast cancer: correlation between dose in internal mammary nodes and prognosis
47. The role of radiotherapy following total mastectomy for patients with early breast cancer
48. Manchester regional breast study: five and ten year results
49. Findings from NSABP protocol no. B‐04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial‐central breast cancers
50. New Edinburgh primary breast cancer trials: report by coordinating committee
51. Treatment of early breast cancer
52. Does simple mastectomy followed by irradiation offer survival comparable to radical procedures?
53. The treatment of operable breast cancer in the south east region of Scotland
54. The value of preoperative radiotherapy in operable mammary carcinoma
55. Postoperative radiation therapy for “early” carcinoma of the breast
56. Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials
57. Decreased survival related to irradiation postoperatively in early operable breast cancer
58. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer
59. Statistical analysis of the analysis of data from retrospective studies of disease
60. Radiotherapy in the postoperative treatment of cancer of the breast: Part I. Critique on the clinical and biometric aspects of the trials
61. Radiotherapy in the postoperative treatment of cancer of the breast: Part II. A re‐examination of Stjernswärds application of the Mantel‐Haenszel statistical method. Evaluation of the effect of the radiation on immune response and suggestions for postoperative radiotherapy
62. Combination chemotherapy as an adjuvant treatment in operable breast cancer
63. Multimodal treatment in operable breast cancer: five year results of the CMF programme
64. Local‐regional failure in patients treated with adjuvant chemotherapy for breast cancer
65. A randomized trial of five and three‐drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer
66. An interim analysis of the randomized surgical adjuvant trial for patients with unfavorable breast cancer [abstract]
67. Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer: analysis at eight years by “Nolvadex” adjuvant trial organization
68. Prolonged disease‐free survival after one course of perioperative adjuvant chemotherapy for node‐negative breast cancer
69. Randomized trial of chemo‐endocrine therapy, endocrine therapy and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis
70. Ten‐year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of 1‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer
71. Adjuvant treatment for stage II (node positive) breast cancer with Adriamycin‐cyclophosphamide (AC) and radiotherapy (XRT)
72. Adjuvant chemotherapy with fluorouracil, doxorubicin and cyclophosphamide with or without bacillus Calmette‐Guerin and with or without irradiation in operable breast cancer: a prospective randomized trial
73. Long‐term follow‐up of L‐PAM and CMF with and without radiation therapy as adjuvant treatment for stage II breast cancer [abstract]
74. Adjuvant radiotherapy and chemotherapy in breast cancer
75. Radiotherapy related adjuvant chemotherapy initiation delay in breast cancer with positive nodes: does it affect prognosis? A Southeastern Cancer Group Study report [abstract]
76. The five year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy
77. The management of resectable stage III breast cancer: the Eastern Cooperative Oncology Group trial [abstract]
78. Evaluation of radiotherapy in high‐risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) trial
79. The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma
80. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from post‐op radiotherapy
81. Radiotherapy for the prevention of local‐regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy
82. Results of irradiation in the treatment of locoregional breast cancer recurrence
83. The role of radiotherapy in the treatment and prevention of local‐regional recurrence following mastectomy for operable breast cancer
84. Analysis of failures following local treatment of isolated local‐regional recurrence of breast cancer
85. Management of locoregional recurrent breast cancer
86. Combined regional and systemic therapy in breast cancer patients with an isolated metastasis with or without prior chemotherapy
87. Review of local soft tissue recurrence of breast cancer irradiated with and without actinomycin‐D
88. Prognostic factors for course of disease and treatment of locally recurrent breast cancer [abstract]
89. Local superficial hyperthermia in combination with low‐dose radiation therapy for palliation of locally recurrent breast carcinoma
90. Chest wall recurrences of breast cancer: results of combined treatment with radiation and hyperthermia
91. Full thickness chest wall resection for recurrent breast carcinoma involving the bony chest wall
92. Chest wall resection in the treatment of local recurrence of breast cancer
93. Photodynamic therapy for chest wall recurrence in breast cancer
94. Breast cancer: experiences with conservation therapy
95. Time course of local recurrence following conservation surgery and radiotherapy for early stage breast cancer
96. Significance of ipsilateral breast tumor recurrence after lumpectomy
97. Conservative surgery and radiotherapy for early breast cancer
98. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis and pathologic findings from mastectomy specimens with implications for treatment
99. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy
100. The outcome of treatment by tumorectomy and radiotherapy of patients with operable breast cancer
101. Mammary recurrences in women younger than forty
102. The impact of tumor size and histology on local control after breast‐conserving surgery
103. The association between very young age and recurrence in the breast in PTS treated with conservative surgery (CS) and radiation therapy (RT)
104. Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer
105. Special morphologic features of invasive mammary carcinomas in women under 40 years of age
106. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25‐year follow‐up
107. Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy
108. Local control and survival of breast cancer treated by limited surgery followed by irradiation
109. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6): II. Relation of local breast recurrence to muiticentricity
110. An assessment of extensive intraductal component as a risk factor for local recurrence after breast conserving therapy
111. Breast‐conserving therapy for macroscopically multiple cancers
112. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast
113. Eight‐year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
114. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node‐negative breast cancer who have estrogen‐receptor‐positive tumors
115. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early‐stage, node‐positive breast cancer: sequencing, timing, and outcome
116. Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast cancer
117. Late breast recurrence after lumpectomy and irradiation
118. Excisional biopsy, axillary node dissection and definitive radiotherapy for stage I and II breast cancer
119. Local recurrence after breast‐conserving surgery and radiotherapy: frequency, time course and prognosis
120. Prognostic significance of breast relapse after conservative treatment in node‐negative early breast cancer
121. Is breast conservation after local recurrence feasible?